Fuse™ Colonoscopy dramatically outperforms standard forward-viewing colonoscopes.
Collins brings formidable business leadership experience to advisory role at Ifbyphone, supporting the company’s accelerated growth plans.
The landscape of medical device investing is as competitive as ever before – putting pressure on companies to present stellar, “better, faster, cheaper” solutions. River Cities’ Rik Vandevenne offers eight qualities that investors are looking for in potential portfolio companies to ensure that you’re putting your best foot forward when presenting to these ever-vigilant investment teams.
Mr. Scott Davis, the Chairman and CEO of UPS (NYSE: UPS) and Mr. Scott Huennekens, President and CEO of Volcano Corporation (NASDAQ: VOLC) have joined the board as EndoChoice looks to more than double its revenue in 2014.
The round was led by River Cities Capital Funds (a growth equity firm focused on healthcare and IT) and brings Ifbyphone’s total funding to more than $30 million.
Revelstoke Capital, Yukon Partners and seven institutional co-investors paid $70 million for a majority equity interest in the wound treatment operator.
Surgiquest and EndoChoice to present at J.P. Morgan Healthcare Conference.
HPCwire Awards recognize outstanding achievements in technology.
Simbionix USA Corporation, the world’s leading provider of medical education and simulation training is pleased to announce having signed a collaboration agreement with I.M. Sechenov First Moscow State Medical University (1st MSMU), the leading national medical higher educational institution in the Russian Federation.
In his new role at Ifbyphone, Mallamud will be charged with all facets of the company’s partnership efforts including developing relationships with key partners, crafting integration strategies, commercialization and partner enablement.